DOCSLIB.ORG

Practical Nurse. Units 18, 19, and 20. Arizona State Dept

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Practical Nurse. Units 18, 19, and 20. Arizona State Dept 6 4 DOCUMENT RESUME ED 221 750 CE 033 943 TITLE Health OccupatiOns Curriculum. Skills and Theory for :Practical Nurse. Units 18, 19, and 20. INSTITUTION Arizona State Dept. of Education, Phoenix. SPONS AGENCY -Department of Education, Washington, DC. PUB DATE 82 NOTE 722p.; For related documents see CE 033 938-942. EDRS PRI,CE mF04/PC29 Plus Postage. DESCRIPTORS *Allied Health Occupations Education; Cultural Context; Drug Use;"Health Occupations; Job Skills; Learning Modples; Mothers; Neonates; *Nurses; *Obstetrics; *Pharmacology; *Practical Nursing; Premature Infants; *Teamwork; Vocational Education IDENTIFIERS Patient Care.; Prenatal Care ABSTRACT Part of a health occupations program, these instructional units colisist of materials for use by those who are studying to become ptactical nurses. Covered in the units are the following: the nursing care Of mothers and newborns (obstetrics, prenatal care and complications, patient needs, care of the newborn, prematurity, medications, and cultural aspects); pharmacology (dosages and solutiöns, administering medications, medications used to treat disorders of various systems of the body, infectious diseases, and allergic:disorders); and integration (team medications, total patient care, the assistant team leader, and thee iole .of the practical nurse). The units are comprised of a series of learning modules, each of which contains a rationale, performance objectives, learning activities and answers, terminology, and posttest. (MN) **t******************************************************************** Reproductions supplied by EDRS are the best that can be made from the original document. *********************************************************************** HEALTH OCCUPATIONS CURRICULUM SKILLS AND THEORY. FOR PRACTICAL NURSE UNITS 18, 19 AND,20 U.S. DEPARTMENT OF EDUCATION NATIONAL INSTITUTE OF EDUCATION "PERMISSION'TO REPRODUCE THIS EDUCATIONAL RESOURCES INFORMATION MATERIAL HAS BEEN GRANTED BY CENTER IENCI Thrs document has been reproduced as reterved horn the person or organizaoon Anginohng it CieMinor changes have been mado to improve reproduction quality Points of view or opinions stated in this docu TO THE EDUCATIONAL RESOURCES mord do not nocssanty represent official NIE INFORMATION CENTER (ERIC)." position or poky ARIZONADEPARTMENT OF EDUCATION Carolyn Warner, Superintendent Dr. Jim kartgraves, Deputy Superintendent Education Services General Operation's Special Program Services .Business Services Div:sion Division Division Division Dr<Thomas R. 4eno Mr. lames J. Brunstein Dr. Ray 6. Ryan Mr. John M. George Associate SuperintendentAssobiate Superintendent Associate SuperintendentAssociate Superintendent STATE BOARD OF EDUCATION STATE BOARD OF VOCATIONAL EDUCATION ARIZONA STATE BOARD OF EDUCATION Dr. George N. Smith President Honorable Carolyn Wainer Executive Officer Julieta Bencomo Member Geraldine Hernbrode Member Leon Maehling Member Pizabeth Packard Member Jack Whiteman Member 0 . CI 1982 by the Arizona Department of Education. All rights reserved. <, First Edition published 1982 Printed in the United tatts of America 1 / ff , No part of this document may be reproauced without written permission from the copyright owner. - _ A., _ \ _ - The Arizona Department of Education is an equal opportuhity employer and educational agency and affirms that it does not discriminate on the basis of race, color, national origin, age, sex, or handi- capping condition. , The contents of th:s publication were developed 'under a grant from the U. S. Department of Education.However,thesecontents donot necessarily represe-4 the policy oi that agency, and you should not assume endorsement by the Federal Government. [20 U.S.C.,1221e-3(a)(1)] , Printed in Phoenix, Arizona by the Arizona Department of Education , in cooperation with Pima Community College Skill Center Total 'Copies Printed . 160 Total Printing Cost .. $2,485.00 Unit Printing Cott.. $15.53 Dat of Printing ... 5/82 4 Unit 18stresSestheprevention,promotionand maintenance of health during the ptenatal, antipartal and the neonatal period, including the complications that are relited to obstetrical nursing. Performance will be evaluated in both the lab and in :he clinical area. Remember that mosf hospitals have different routines and procedures. Some of the assessment and procedulz information will vary depending on your facility. In addition to basic preparation for maternal child care, this unit presents related ctiltural aspects that will ,be an .importantpirt.otyour_clinical assessment. NURSING CARE OF MOTHERS AND NEWBORNS' Module Al - Introduction to Obstetrics Module A2 - Prenatal tare and Complications Module B- Meeting PatierWsNeeds in Labor and Delivery Module C - Meeting Patient's Needs During the Puerperium MOdule D- Evaluating Fetal Condition Module El - General Characteristics, Appearance and Nursing Care of the Newborn Module E2 - Problems of the Newborn Module E3 - Prematurity, Module F- Medications Module G - CulturalAspectsin,theNursing Care of Mothers and Newbornt Terminology Post Tests: 1. Modules Al and A2 2. Module B . 3. Module C and D 4. Module El, E2 and E3 Module F 6.Mcdule G (class discussion only) When you have completed the learning activities and are ready for a test or wish to challenge a test, please see your instructor. Suggested Resources The following texts and audiovisual aidefa will supplement the learning materials for this unit.If you are unable to locate these materials, your instructor will assist you.An additional source of information is in Module G on the cultural aspects of care. 1. Bethea, Doris C., RN., B.S:, M.S.IntroductorY Maternity Nursing.J.B. Lippincott Company, Philadelphia, PA, 1979. 2. Clatoen, Joy Princton, Margaret Hemp Flook, gonnie Ford, Marilyn M. Green, Elda S. popiel.Maternity Nursing Today. McGraw Hill Book Company, New York, NY, 1977. 3. Falconer-Patterson,Güstafson. CurrentDrug Bdok. W.B.SaundersCo., Philadelphia, PA1 1980-81. 4. Garney,._Mathew, A.D.T. Govan, C. Hodge. Obstetrics Illustrated. Churchill Livingstov, New York, 1974. 5. Kalafatich, Andrew J., Dorothy R. Meeks and Barbara Jones.Maternal and Child Health. Littlefield, Adams and Co., 1977. 6. Lamberson, Eleanor C. Child Health: Basics for Primary Care. Appleton, Century, Crofts, New York, 1980. 7.,Skelley, Esther G., R.M., M.A. Nedications and Mathematic s. for the Nurse. Delmar. Publishers, Albany, New York, 1976. , 8. Physician& Desk Reference For Nonprescription Drugs.Medical Economics, NJ, 1980. Audiovisuals 1. IntroductiOn to Infant Care, Trainex Corporation, Garden Grove, CA. Health Care of the Normal Infant Skin Care and Bathihg Prepatation Infant Care and Breast Feeding Bottle Feeding 'Bathing the-Infant Emergency Childbirth,.Part I Emergency Childbirth, Part II Post-Partum Care 2. Huffian Birth, Multiple Birth, Twins, by J.B. Lippincott Company, 1974. (16 mm Human Birth, Vertex Delivery Spontaneous 10 NbRSING CARE OF MOTHERS AND NEWBORNS Module Al - In =ductal 40 Obstetrics RATIONALE To live safe arid effective care to the patient during Pregnancy, you will need a fundamental knowledge of pregnancy, maternity care and tielated infori-nation. PERFORMANCE OBJECTIVES To the instructor's satisfaction, you will: 1. Identify current problems in maternity care as discussed in this module. 4 2. Recognize the purpose of miternity care. 3. Identify three areas in which a birth certificate provides legal proof. 4. Identify the primary parts of the female and the male reproductive systems and explain their functions. 5. Identify terms specific to pregnancy. 6. Recognize the signs and symptoms of pregnancy. /.Recognize the f?hysical and emotional changes that occur during pregnancy. 8.Recognize the stages of development of the fetus. 9. Recognize normal fetal circulation, the vessels in the umbilical cord and the changes that take place in fetal circulation at birth. 1 10. Identify the average number of days in a pregnancy. 11. Identify the method for estimating the date of conception. 12. Identify the hormones that affect reproduction and recognize their physiological effect. CLINICAL oiszEcrivEs To your instructor's satisfktion, when given a clinical assignment, you will: 1. Identify ten signs and syrntoms of pregnancy observed in a patient. Describe and report your observations to your instructor and construct nursing notes specific to the patient. 7 .. 1 18.A1.2 LEARNING ACTIVITIES Directions:All the information you need to complete this module is included in the textbook, IntroductoryMaternity Nursing, by Doris C. Bethea, J.B. Lippincott Company, Philadelphia, PA,1979 and this module.The - exercises in the module are included to help you learn the information presented in the textbook. After you have completed an exercise, go back and check your answers with the material in the chapter.,If you hive any questions, go to your instructor. / ACTIVITY 11. Maternity Care Today Directions:Read Chapter 1, pages 1-11, in yotir textbook.After you have read this chapter, define the terms 1-2, then complete the remaining exercises.You may use your book to do the exercises and check your work.. 1. Obstetrics: , o 2. Nurse-Midwife: 1. List and describe five current problems in maternity care. k. a. b. c. o d. e. 4.The birth certificate provides legal proof in what three areas. , a. 'a b c. C- s .18.A1.3 LEARNING ACTIVITiES - continued \ 0 , ACTIVITY #2. The Reproductive System , Directions:Read pages 127.32, Chapter2, in your textbook.After ypu have read the chapter, define the terms 1-53. TheFemale Reproductive
Load more

Recommended publications
  • United States Patent Office
    3,092,548 United States Patent Office Patented June 4, 1963 2 are the various side effects that occur in an appreciable 3,092,548 number of patients, the foremost of which are a blurring METHOD OF TREATING PEPTICULCERS WITH PANTOTHENECACD of vision, drowsiness and a general dry condition mani Albert G. Worton, Columbus, Ohio, assignor to The fested by a retarded salivation, reduction of perspiration Warren-Teed Products Company, Columbus, Ohio, a 5 and diminished urinary output. Other side effects which corporation of Ohio occur in some cases are glaucoma, stimulation of the cen No Drawing. Filed Oct. 27, 1960, Ser. No. 65,256 trol nervous system and in severe cases cardiac and respi 5 Claims. (Ci. 67-55) ratory collapse. These side effects increase to Some de gree with the increase in dosage. Despite the side effects This invention relates to preparation adapted for use O these compounds are fairly selective and highly effective in treating disorders of the gastro-intestinal tract, more in decreasing the volume and acidity of gastric secretion particularly in treating peptic ulcer, both of the duodenal and in reducing gastrointestinal motility. and gastric type, for hyperacidity, hypertropic gastritis, Understandably, the main problem in the past has been splenic flexure syndrome, biliary dyskinesia (postchole to provide a dosage of anticholinergic drug which will cystectomy syndrome) and hiatal hernia or other condi achieve the most beneficial results possible and yet mini tions where anticholinergic effect, either spasmolytic or mize the undesired side effects. One of the objects of antisecretory is indicated or where antiuicerogenic effect this invention is to provide novel compositions containing is indicated.
    [Show full text]
  • Extrinsic Factors Influencing Fetal Deformations and Intrauterine
    Hindawi Publishing Corporation Journal of Pregnancy Volume 2012, Article ID 750485, 11 pages doi:10.1155/2012/750485 Review Article Extrinsic Factors Influencing Fetal Deformations and Intrauterine Growth Restriction Wendy Moh, 1 John M. Graham Jr.,2 Isha Wadhawan,2 and Pedro A. Sanchez-Lara1 1 Center for Craniofacial Molecular Biology, Ostrow School of Dentistry and Children’s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, 4650 Sunset Boulevard, MS 90, Los Angeles, CA 90027, USA 2 Cedars-Sinai Medical Center, Medical Genetics Institute and David Geffen School of Medicine at UCLA, 8700 Beverly Boulevard, PACT Suite 400, Los Angeles, CA 90048, USA Correspondence should be addressed to Pedro A. Sanchez-Lara, [email protected] Received 24 March 2012; Revised 4 June 2012; Accepted 4 June 2012 Academic Editor: Sinuhe Hahn Copyright © 2012 Wendy Moh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The causes of intrauterine growth restriction (IUGR) are multifactorial with both intrinsic and extrinsic influences. While many studies focus on the intrinsic pathological causes, the possible long-term consequences resulting from extrinsic intrauterine physiological constraints merit additional consideration and further investigation. Infants with IUGR can exhibit early symmetric or late asymmetric growth abnormality patterns depending on the fetal stage of development, of which the latter is most common occurring in 70–80% of growth-restricted infants. Deformation is the consequence of extrinsic biomechanical factors interfering with normal growth, functioning, or positioning of the fetus in utero, typically arising during late gestation.
    [Show full text]
  • WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No
    WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No. : US 10 , 307 ,409 B2 Chase et al. (45 ) Date of Patent: Jun . 4 , 2019 ( 54 ) MUSCARINIC COMBINATIONS AND THEIR (52 ) U . S . CI. USE FOR COMBATING CPC . .. .. A61K 31/ 4439 (2013 . 01 ) ; A61K 9 /0056 HYPOCHOLINERGIC DISORDERS OF THE (2013 . 01 ) ; A61K 9 / 7023 ( 2013 . 01 ) ; A61K CENTRAL NERVOUS SYSTEM 31 / 166 ( 2013 . 01 ) ; A61K 31 / 216 ( 2013 . 01 ) ; A61K 31 /4178 ( 2013 .01 ) ; A61K 31/ 439 (71 ) Applicant: Chase Pharmaceuticals Corporation , ( 2013 .01 ) ; A61K 31 /44 (2013 . 01 ) ; A61K Washington , DC (US ) 31/ 454 (2013 .01 ) ; A61K 31/ 4725 ( 2013 .01 ) ; A61K 31 /517 (2013 .01 ) ; A61K 45 / 06 ( 72 ) Inventors : Thomas N . Chase , Washington , DC (2013 . 01 ) (US ) ; Kathleen E . Clarence -Smith , ( 58 ) Field of Classification Search Washington , DC (US ) CPC .. A61K 31/ 167 ; A61K 31/ 216 ; A61K 31/ 439 ; A61K 31 /454 ; A61K 31 /4439 ; A61K (73 ) Assignee : Chase Pharmaceuticals Corporation , 31 /4175 ; A61K 31 /4725 Washington , DC (US ) See application file for complete search history. ( * ) Notice : Subject to any disclaimer, the term of this (56 ) References Cited patent is extended or adjusted under 35 U . S . C . 154 (b ) by 0 days . U . S . PATENT DOCUMENTS 5 ,534 ,520 A 7 / 1996 Fisher et al. ( 21) Appl . No. : 15 /260 , 996 2008 /0306103 Al 12 /2008 Fisher et al. 2011/ 0021503 A1* 1/ 2011 Chase . .. A61K 31/ 27 ( 22 ) Filed : Sep . 9 , 2016 514 / 215 2011/ 0071135 A1 * 3 / 2011 Chase . .. .. .. A61K 31/ 166 (65 ) Prior Publication Data 514 / 215 2011 /0245294 Al 10 / 2011 Paborji et al.
    [Show full text]
  • Neonatal Orthopaedics
    NEONATAL ORTHOPAEDICS NEONATAL ORTHOPAEDICS Second Edition N De Mazumder MBBS MS Ex-Professor and Head Department of Orthopaedics Ramakrishna Mission Seva Pratishthan Vivekananda Institute of Medical Sciences Kolkata, West Bengal, India Visiting Surgeon Department of Orthopaedics Chittaranjan Sishu Sadan Kolkata, West Bengal, India Ex-President West Bengal Orthopaedic Association (A Chapter of Indian Orthopaedic Association) Kolkata, West Bengal, India Consultant Orthopaedic Surgeon Park Children’s Centre Kolkata, West Bengal, India Foreword AK Das ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD. New Delhi • London • Philadelphia • Panama (021)66485438 66485457 www.ketabpezeshki.com ® Jaypee Brothers Medical Publishers (P) Ltd. Headquarters Jaypee Brothers Medical Publishers (P) Ltd. 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd. Jaypee-Highlights Medical Publishers Inc. Jaypee Brothers Medical Publishers Ltd. 83, Victoria Street, London City of Knowledge, Bld. 237, Clayton The Bourse SW1H 0HW (UK) Panama City, Panama 111, South Independence Mall East Phone: +44-2031708910 Phone: +507-301-0496 Suite 835, Philadelphia, PA 19106, USA Fax: +02-03-0086180 Fax: +507-301-0499 Phone: +267-519-9789 Email: [email protected] Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd. Jaypee Brothers Medical Publishers (P) Ltd. 17/1-B, Babar Road, Block-B, Shaymali Shorakhute, Kathmandu Mohammadpur, Dhaka-1207 Nepal Bangladesh Phone: +00977-9841528578 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2013, Jaypee Brothers Medical Publishers All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher.
    [Show full text]
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • SUBGALEAL HEMATOMA Sarah Meyers MS4 Ilse Castro-Aragon MD CASE HISTORY
    SUBGALEAL HEMATOMA Sarah Meyers MS4 Ilse Castro-Aragon MD CASE HISTORY Ex-FT (37w6d) male infant born by low transverse C-section for arrest of descent and chorioamnionitis to a 34-year-old G2P1 mother. The infant had 1- and 5-minute APGAR scores of 9 and 9, weighed 3.625 kg (54th %ile), and had a head circumference of 34.5 cm (30th %ile). Following a challenging delivery of the head during C/s, the infant was noted to have left-sided parietal and occipital bogginess, and an ultrasound was ordered due to concern for subgaleal hematoma. PEDIATRIC HEAD ULTRASOUND: SUBGALEAL HEMATOMA Superficial pediatric head ultrasound showing moderately echogenic fluid collection (green arrow), superficial to the periosteum (blue arrow), crossing the sagittal suture (red arrow). Findings on U/S consistent with large parieto-occipital subgaleal hematoma. PEDIATRIC HEAD ULTRASOUND: SUBGALEAL HEMATOMA Superficial pediatric head ultrasound showing moderately echogenic fluid collection (green arrow), consistent with large parieto-occipital subgaleal hematoma. CLINICAL FOLLOW UP - Subgaleal hematoma was confirmed on ultrasound and the infant was transferred from the newborn nursery to the NICU for close monitoring, including hourly head circumferences and repeat hematocrit measurements - Serial head circumferences remained stable around 34 cm and hematocrit remained stable between 39 and 41 throughout hospital course - The infant was subsequently treated with phototherapy for hyperbilirubinemia, thought to be secondary to resorption of the SGH IN A NUTSHELL:
    [Show full text]
  • Wo 2010/075090 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 1 July 2010 (01.07.2010) WO 2010/075090 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07D 409/14 (2006.01) A61K 31/7028 (2006.01) kind of national protection available): AE, AG, AL, AM, C07D 409/12 (2006.01) A61P 11/06 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2009/068073 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 15 December 2009 (15.12.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/122,478 15 December 2008 (15.12.2008) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): AUS- ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, PEX PHARMACEUTICALS, INC.
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • Federal Register/Vol. 77, No. 115/Thursday, June 14, 2012
    Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices 35691 TABLE 1—LIST OF SAFETY AND EFFECTIVENESS SUMMARIES FOR APPROVED PMAS MADE AVAILABLE FROM JANUARY 1, 2012, THROUGH MARCH 31, 2012—Continued PMA No., Docket No. Applicant Trade name Approval date P060008.S046, FDA–2012–M–0210 ... Boston Scientific Corp ......................... TAXUS Liberte´ Paclitaxel-Eluting Cor- February 22, 2012. onary Stent System (Monorail and Over-The-Wire Delivery Systems). P030025.S086, FDA–2012–M–0209 ... Boston Scientific Corp ......................... TAXUS Express2 Paclitaxel-Eluting February 22, 2012. Coronary Stent System (Monorail and Over-The-Wire Delivery Sys- tems). P110023, FDA–2012–M–0221 ............ ev3, Inc ................................................ Everflex Self-Expanding Peripheral March 7, 2012. Stent System (Everflex). P070004, FDA–2012–M–0250............ Sientra, Inc.......................................... SIENTRA Silicone Gel Breast Im- March 9, 2012. plants. II. Electronic Access LOCATION: The meeting will be held at submissions. In the process of Persons with access to the Internet the FDA White Oak Campus, 10903 considering these changes, FDA has may obtain the documents at http:// New Hampshire Ave., Bldg. 31 previously made available for comment www.fda.gov/MedicalDevices/ Conference Center, Great Room 1503, versions of documents that support ProductsandMedicalProcedures/ Silver Spring, MD 20993. The following making regulatory submissions in DeviceApprovalsandClearances/ link contains public meeting attendee electronic format using the (eCTD) information as well as frequently asked PMAApprovals/default.htm and http:// specifications. These draft documents questions and answers regarding public www.fda.gov/MedicalDevices/ represented FDA’s major updates to meetings at White Oak: http:// ProductsandMedicalProcedures/ Module 1 of the eCTD based on www.fda.gov/AboutFDA/ DeviceApprovalsandClearances/ previous comments.
    [Show full text]
  • Prevalence and Characterization of Neonatal Skin Disorders in the First
    J Pediatr (Rio J). 2017;93(3):238---245 www.jped.com.br ORIGINAL ARTICLE Prevalence and characterization of neonatal skin ଝ,ଝଝ disorders in the first 72 h of life a,∗ b b Flávia Pereira Reginatto , Damie DeVilla , Fernanda M. Muller , c c b a,c Juliano Peruzzo , Letícia P. Peres , Raquel B. Steglich , Tania F. Cestari a Universidade Federal do Rio Grande do Sul (UFRGS), Programa de Pós-graduac¸ão em Saúde da Crianc¸a e Adolescente, Porto Alegre, RS, Brazil b Complexo Hospitalar Santa Casa de Porto Alegre, Departamento de Dermatologia, Porto Alegre, RS, Brazil c Universidade Federal do Rio Grande do Sul (UFRGS), Hospital de Clínicas de Porto Alegre (HCPA), Departamento de Dermatologia, Porto Alegre, RS, Brazil Received 9 May 2016; accepted 16 June 2016 Available online 19 November 2016 KEYWORDS Abstract Newborn; Objective: To determine the prevalence of neonatal dermatological findings and analyze Neonatology; whether there is an association between these findings and neonatal and pregnancy charac- teristics and seasonality. Child health services; Methods: Newborns from three maternity hospitals in a Brazilian capital city were randomly Child health; selected to undergo dermatological assessment by dermatologists. Infant care; Results: 2938 neonates aged up to three days of life were randomly selected, of whom 309 Skin manifestations were excluded due to Intensive Care Unit admission. Of the 2530 assessed neonates, 49.6% were Caucasians, 50.5% were males, 57.6% were born by vaginal delivery, and 92.5% of the moth- ers received prenatal care. Some dermatological finding was observed in 95.8% of neonates; of these, 88.6% had transient neonatal skin conditions, 42.6% had congenital birthmarks, 26.8% had some benign neonatal pustulosis, 2% had lesions secondary to trauma (including scratches), 0.5% had skin malformations, and 0.1% had an infectious disease.
    [Show full text]
  • Epidemiological Aspects of Neonatal Jaundice and Its Relationship with Demographic Characteristics in the Neonates Hospitalized in Government Hospitals in Ilam, 2013
    Original article J Bas Res Med Sci 2014; 1(2):48-52. Epidemiological aspects of neonatal jaundice and its relationship with demographic characteristics in the neonates hospitalized in government hospitals in Ilam, 2013 Ashraf Direkvand-Moghadam 1, Ali Delpisheh 2, Mosayeb Mozafari *3, Azadeh Direkvand-Moghadam 4, Parvaneh Karzani 4, Parvin Saraee 4, Zahra Safaripour 4, Nasim Mir-Moghadam 4, Mrjan Teimour Pour4 1. Prevention of Psychosocial Injuries Research Center; Department of Midwifery, Ilam University of Medical Sciences, Ilam, Iran 2. Department of Clinical Epidemiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran 3. Department of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran 4. Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran * Corresponding author: Tel: +98 8412227123; fax: +98 8412227123 Address: Dept of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran E-mail: [email protected] Receive d 21/7/2014; revised 28/7/2014; accepted 2/8/2014 Abstract Introduction: Jaundice is one of the hospitalization causes in term and preterm infants. Considering to the side effects of jaundice, the present study aimed to investigate the prevalence and risk factors associated with jaundice in neonates hospitalized in government hospitals in Ilam. Materials and methods: In a case - control study, 384 neonates were enrolled. All neonates hospitalized in Mustafa Khomeini and Imam Khomeini hospital were enrolled in the study. Neonates’ deaths due other causes were excluded from the study. Data collected through a questionnaire. The validity of the questionnaire was determined using content validity and its reliability was determined 84% using Cronbach's alpha coefficient.
    [Show full text]
  • MNCY SCN Postpartum Newborn Pathway
    Alberta Pregnancy Pathways Adopted from Perinatal Services BC, 2015. While every attempt has been made to ensure that the information contained herein is clinically accurate and current, AHS acknowledges that many issues remain controversial, and, therefore, may be subject to practice interpretation. Developed by the Maternal Newborn Child & Youth Strategic Clinical Network™ – Version 4.2 September 2020 Revision Control Version Revision Date Summary of Revisions Author V-1.0 September 2016 Original Document MNCY SCN™ Postpartum Newborn Working Group V-2.0 April 2017 Refer to Summary of Revisions – separate document Ursula Szulczewski, Manager, MNCY SCN™ V-2.1 September 2017 Revisions based on provincial chart audit and staff evaluation Debbie Leitch, Executive Director, MNCY SCNTM V-2.2 March 2018 Revisions to pathway forms Debbie Leitch, Executive Director, MNCY SCNTM Clarification around sedation score and assessment criteria for intrapsinal and intrathecal blocks and epidurals. V-3.0 September 2018 Addition to initial newborn assessment completion guide – Debbie Leitch, Executive Director, MNCY SCNTM assessment of newborn palette to include palpation and visualization. V-3.1 October 2018 Clarification of assessment for motor block. Debbie Leitch, Executive Director, MNCY SCNTM Addition of safe swaddling to comfort or soothe and link to V-4.0 January 2019 Healthy Families, Healthy Children video. Debbie Leitch, Executive Director, MNCY SCNTM Addition of supplementation volumes for breast fed infants. Pg 86 Supplementation volumes to refer to term babies only (not late preterm). Pg 90 Formula volume (for baby not breastfeeding) returned to previous 30ml/kg/24 hours – follow hunger cues. TM V-4.1 March 2019 Pg 108 Newborn stools 48-72 hours: 3 or more transitional Debbie Leitch, Executive Director, MNCY SCN stools/day; 72 hours – 4-6 weeks: 3 or more stools/day Pg 104 Lab bilirubin or transcutaneous bilirubin measured on all infants within 24 hours of birth and prior to discharge.
    [Show full text]